The Impact of Selecting a High Hemoglobin Target Level on Health-Related Quality of Life for Patients With Chronic Kidney Disease
This systematic review aims to look at the health-related quality of life (HQOL) impact of target hemoglobin (Hb) levels. Results of this meta-analysis suggest that levels in excess of 120 g/L lead to small, but not meaningful improvements in HQOL. The authors conclude that, in balance with safety concerns, 90 to 120 g/L should be the preferred Hb target.
- Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy
- Effect of Neutral-pH, Low–Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis
- KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.